Results 41 to 50 of about 9,584,814 (404)
Surgical Case Reports, 2021 Background Renal cell carcinoma (RCC) is a primary tumor with the highest frequency of pancreatic metastasis. Although surgical resection can improve the prognosis of some patients with pancreatic metastasis of RCC (PM-RCC), the role of palliative ...
Shinya Sakamoto +6 more
doaj +1 more source
Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
Frontiers in Oncology, 2022 Tumor necrosis factor (TNF) receptor type II (TNFR2) is expressed in various tumor cells and some immune cells, such as regulatory T cells and myeloid-derived suppressing cells. TNFR2 contributes a lot to the tumor microenvironment.
Muchun Li +16 more
doaj +1 more source
Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer [PDF]
, 2016 Diabetes mellitus is a group of diseases defined by persistent hyperglycaemia. Type 2 diabetes, the most prevalent form, is characterised initially by impaired insulin sensitivity and subsequently by an inadequate compensatory insulin response.
Andersen, Dana K +13 more
core +2 more sources
Pancreatic cystosis in cystic fibrosis. Sometimes a bike ride can help you decide [PDF]
, 2020 Pancreatic cystosis (PC) is an uncommon manifestation of pancreas involvement in cystic fibrosis (CF), characterized by the presence of multiple macrocysts partially or completely replacing pancreas.
Di Gaeta, A. +4 more
core +1 more source
Frontiers in Cell and Developmental Biology, 2021 Tumor microenvironment comprises of a variety of cell types, which is quite complex and involved in chemotherapy and immune checkpoint blockage resistance.
Hao Qian +31 more
doaj +1 more source
Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access (R) GI Monitor assay on the UniCel (R) Dxl 800 Immunoassay System [PDF]
, 2008 Background: Gastrointestinal cancer antigen CA19-9 is known as a valuable marker for the management of patients with pancreatic cancer. Methods: The analytical and clinical performance of the Access(R) GI Monitor assay (Beckman Coulter) was evaluated on ...
Barone D +15 more
core +3 more sources
Primary extranodal diffuse large B‐cell lymphoma: Molecular features, treatment, and prognosis
Aging and Cancer, Volume 3, Issue 3-4, Page 133-146, September-December 2022., 2022 One‐third of DLBCL arises from extranodal organs and is challenging to manage. Molecular features are critical to elucidate the differences in clinical features, predict the disease prognosis, and improve effective targeted therapeutic strategies. Abstract Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin's lymphoma and ...
Si‐Yuan Chen +3 more
wiley +1 more source
Frontiers in Medicine, 2021 Aim: The purpose of our study was to conduct a retrospective analysis to compare the effectiveness of transjugular intrahepatic portosystemic shunts (TIPS) in the treatment of patients with cirrhosis with or without portal vein thrombosis (PVT).Methods ...
Hong-Liang Wang +23 more
doaj +1 more source
DeformableFormer: Classification of Endoscopic Ultrasound Guided Fine Needle Biopsy in Pancreatic Diseases [PDF]
arXiv, 2023 Endoscopic Ultrasound-Fine Needle Aspiration (EUS-FNA) is used to examine pancreatic cancer. EUS-FNA is an examination using EUS to insert a thin needle into the tumor and collect pancreatic tissue fragments. Then collected pancreatic tissue fragments are then stained to classify whether they are pancreatic cancer.
arxiv
Haemorrhage in pancreatic disease
Journal of British Surgery, 1989 Abstract Haemorrhage is a life-threatening complication in pancreatic disease. Twenty-five patients with this complication are described; 15 had major bleeding, nine had minor bleeding and one patient had a pseudoaneurysm identified at operation.
S. Shankar, R. C. G. Russell
openaire +3 more sources